MultiPlan Corporation

The AMA and ISMS have filed a lawsuit against MultiPlan, alleging that the data analytics agency is at the center of a price-fixing conspiracy with commercial health insurance companies. This has resulted in lower payments for out-of-network healthcare services, harming both patients and physicians.

Related tickers: MPLN.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. Mesoblast Limited (NASDAQ: MESO) On Jan. 19, the FDA granted Rare Pediatric Disease Designation to Mesoblast's Revascor® for treating children with congenital heart disease. The ...

Related tickers: NEOG, HUM, MESO, MPLN.